SIGA Stock, SIGA Technologies Inc. Information

We are a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats. Our lead product is Tecovirimat, also known as ST , an orally administered antiviral drug that targets orthopoxviruses. While Tecovirimat is not yet licensed as safe or effective by the U.S. Food amp Drug Administration, it is a novel small molecule drug that is being delivered to the Strategic National Stockpile under Project BioShield.